ストックスクリーナーアプリを入手
0.3627
6.97%
-0.0319
前日終値:
$0.3946
開ける：
$0.3781
24時間の取引高:
1.07M
Relative Volume:
1.44
時価総額：
$15.26M
収益：
-
当期純損益:
$-17.78M
株価収益率:
-0.6604
EPS:
-0.5492
ネットキャッシュフロー:
$-10.52M
1週間 パフォーマンス:
-12.78%
1か月 パフォーマンス:
-33.16%
6か月 パフォーマンス:
-63.65%
1年 パフォーマンス:
-87.92%
1日の値動き範囲:
$0.3611
$0.389
1週間の範囲:
$0.3642
$0.4201
52週間の値動き範囲:
$0.3642
$3.89
Fibrobiologics Inc Stock (FBLG) Company Profile
FBLG を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
FBLG
Fibrobiologics Inc
|
0.3643 | 16.53M | 0 | -17.78M | -10.52M | -0.5492 |
|
VRTX
Vertex Pharmaceuticals Inc
|
426.00 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
629.60 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.82 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
837.92 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
184.38 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Fibrobiologics Inc Stock (FBLG) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2024-12-12 | 開始されました | Rodman & Renshaw | Buy |
| 2024-10-30 | 開始されました | H.C. Wainwright | Buy |
| 2024-09-24 | 開始されました | Maxim Group | Buy |
Fibrobiologics Inc (FBLG) 最新ニュース
How FibroBiologics Inc. (SG0) stock performs in easing cyclesEarnings Performance Report & Safe Capital Growth Trade Ideas - newser.com
Is FibroBiologics Inc. (SG0) stock included in top ETFsInflation Watch & Risk Controlled Stock Pick Alerts - newser.com
What earnings revisions data tells us about FibroBiologics Inc.Oil Prices & AI Forecast Swing Trade Picks - newser.com
Should you hold or exit FibroBiologics Inc. nowJuly 2025 Technicals & Community Trade Idea Sharing Platform - newser.com
How FibroBiologics Inc. stock performs in interest rate cyclesEarnings Summary Report & Risk Managed Investment Signals - newser.com
D. Boral Capital Maintains FibroBiologics (FBLG) Buy Recommendation - Nasdaq
What’s the recovery path for long term holders of FibroBiologics Inc.Trade Signal Summary & Risk Adjusted Buy and Sell Alerts - newser.com
When is the best time to exit FibroBiologics Inc.2025 Earnings Surprises & Reliable Entry Point Trade Alerts - newser.com
How sustainable is FibroBiologics Inc. stock dividend payoutLayoff News & Accurate Intraday Trading Signals - newser.com
FBLG Analyst Ratings: Jason Kolbert Maintains Buy Stance | FBLG Stock News - GuruFocus
Is FibroBiologics Inc. (SG0) stock ideal for retirement investorsJuly 2025 Selloffs & Consistent Income Trade Ideas - newser.com
Is FibroBiologics Inc. (SG0) stock resilient in recession scenariosDividend Hike & Smart Allocation Stock Reports - newser.com
How dovish Fed policy supports FibroBiologics Inc. (SG0) stockWeekly Investment Recap & Smart Investment Allocation Tips - newser.com
Identifying reversal signals in FibroBiologics Inc.Weekly Profit Report & Community Verified Trade Signals - newser.com
Sector ETF performance correlation with FibroBiologics Inc.Trade Analysis Report & Verified Chart Pattern Trade Signals - newser.com
Real time scanner hits for FibroBiologics Inc. explainedStock Surge & Free Technical Confirmation Trade Alerts - newser.com
Analyzing recovery setups for FibroBiologics Inc. investorsQuarterly Trade Report & Breakout Confirmation Alerts - newser.com
What data driven models say about FibroBiologics Inc.’s futureTrade Signal Summary & Short-Term High Return Strategies - newser.com
Why institutional investors increase stakes in FibroBiologics Inc. (SG0) stock2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
FibroBiologics, Inc. (FBLG) Analyst insights, Price targets and Recommendations - Yahoo! Finance UK
What drives FibroBiologics Inc stock priceTrading Volume Surges & Free Tools to Monitor Market Corrections - earlytimes.in
FibroBiologics Advances Manufacturing and IND Preparations for Clinical Trials of CYWC628, CYPS317, and CYMS101 - Quiver Quantitative
FibroBiologics Reports Third Quarter 2025 Financial Results and Provides Corporate Update - GlobeNewswire
FibroBiologics, Inc. SEC 10-Q Report - TradingView
FibroBiologics, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 - MarketScreener
FibroBiologics warns on going concern amid $15M notes - Stock Titan
Is FibroBiologics Inc. stock gaining market shareMarket Activity Recap & Precise Buy Zone Tips - newser.com
Fibrobiologics Inc (FBLG) 財務データ
収益
当期純利益
現金流量
EPS
1.24%
0.84%
大文字化:
|
ボリューム (24 時間):